Company Update (NYSE:MCK): McKesson Completes the Acquisitions of Vantage Oncology and Biologics

[Business Wire] – McKesson Corporation , a leading international healthcare services and information technology company, announced today that it has completed the previously announced acquisitions of Vantage Oncology, LLC, and Biologics, Inc., for a combined purchase price of approximately $1.2 billion. Read more on this. McKesson Corporation (MCK) , valued at $36.56B, started trading this morning at $157.24. Looking at the equity, the company’s one day range is $157.00 to $161.78 with its 52-week range being $148.29 to $243.61. MCK shares are currently priced at 12.40x this year’s forecasted earnings, which makes them relatively expensive compared to the industry’s 2.82x earnings multiple. The company pays shareholders $1.12 per share annually in dividends, yielding 0.71%. In a review of the consensus earnings estimate this quarter, 16 sell-side analysts are looking at $3.05 per share, which would be $0.11 better than the year-ago quarter and a $0.19 sequential decrease. In looking at the bigger picture, the full-year EPS estimate of $12.68 would be a $1.57 better when compared to the previous year’s annual results. The quarterly earnings estimate is predicated on a consensus revenue forecast of $46.91 Billion. If reported, that would be a 4.43% increase over the year-ago quarter. In terms of ratings, Credit Suisse Initiated MCK at Neutral (Mar 16, 2016). Previously, Mizuho downgraded MCK from Buy to Neutral. When considering if perhaps the stock is under or overvalued, the average price target is $197.03, which is 25.31% above where the stock opened this morning. See more in (NYSE:MCK) Similar Articles: Company Update (NYSE:MCK): McKesson Expands Oncology Expertise With the Acquisitions of Vantage Oncology and Biologics Company Update: McKesson Corporation (NYSE:MCK) – McKesson Corporation Fiscal 2016 Third Quarter Conference Call Scheduled for January 27, 2016 Company Update: McKesson Corporation (NYSE:MCK) – McKesson Corporation to Present at the 24th Annual Credit Suisse Healthcare Conference